Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.47 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27980713 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTZDHHC7MAPK1 | |
| SCHEMBL7649131 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTZDHHC7MAPK1 | |
| SCHEMBL2520207 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTZDHHC7MAPK1 | |
| SCHEMBL29065655 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTZDHHC7MAPK1 | |
| SCHEMBL7645314 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTZDHHC7MAPK1 | |
| SCHEMBL7644829 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTZDHHC7MAPK1 | |
| SCHEMBL29175475 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTZDHHC7MAPK1 | |
| SCHEMBL8518835 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTZDHHC7MAPK1 | |
| SCHEMBL7645699 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTZDHHC7MAPK1 | |
| SCHEMBL2518119 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTZDHHC7MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6262029-B1 | TRITERPENE AGLYCONE CORE SUBSTITUTED AT POSITIONS 3 AND 28 WITH A MONOSACCHARIDE OR AN OLIGOSACCHARIDE WHICH CAN BE THE SAME OR DIFFERENT, AND HAVING AN ALDEHYDE GROUP ATTACHED TO THE CORE, PREFERABLY AT THE 4-POSITION. | GALENICA PHARMACEUTICALS, INC. | 2001-07-17 | — | — | US | disclosed |
| WO-2000009075-A2 | CHEMICALLY MODIFIED SAPONINS AND THE USE THEREOF AS ADJUVANTS | GALENICA PHARMACEUTICALS, INC. (US) | 2000-02-24 | — | — | WO | disclosed |